AIMS, OBJECTIVES AND SCOPE

Journal Aims

The Journal of Biomolecules, Pathogenesis and Therapeutics (JBPT) aims to serve as a high-quality, peer-reviewed platform for the dissemination of original and innovative research in the biomedical, clinical, and translational sciences. The journal is dedicated to advancing the scientific understanding of interdisciplinary research that integrates molecular biology, pathophysiology, clinical pathogenesis, pharmacology, diagnostic methodologies, drug development and targeted therapeutic interventions.

Primary Objectives

The primary objectives of JBPT are to:

  • Promote interdisciplinary research integrating biomolecular science, pathology, clinical diagnostics, pharmacology and therapeutics.
  • Encourage high-quality basic, translational, drug and clinical research with direct relevance to disease diagnosis, management, and prevention.
  • Provide a credible publication platform for early-career researchers, clinicians, and laboratory scientists, while maintaining rigorous peer-review standards.
  • Support ethical research practices and transparent scholarly communication in accordance with international publication guidelines.
  • Facilitate the global exchange of scientific knowledge by encouraging submissions from both national and international researchers.

Core Focus and Research Interface

JBPT focuses on the interface of biomolecular sciences, disease mechanisms, pharmacology and therapeutic developments. The journal provides an international platform for studies that advance the molecular understanding of human diseases and translate these insights into clinical diagnostics, preventive medicine, and therapeutic applications.

The journal publishes basic, translational, and clinical research focusing on biomolecules such as proteins, nucleic acids, glycans, lipids, and immune mediators involved in infectious, inflammatory, metabolic, genetic, and neoplastic disorders. Emphasis is placed on mechanistic investigations, host–pathogen interactions, biomarker discovery, molecular diagnosis, pharmacological mechanisms and the evaluation of emerging therapeutic strategies. Submissions on vaccines, biologics, precision medicine, diagnostic biomarkers, molecular diagnostics, and molecular imaging approaches are highly welcomed.

JBPT accepts basic, translational, clinical, and computational studies, including experimental, observational, and in silico research, provided they demonstrate methodological rigor and clear relevance to the journal’s scope.

Acceptable Article Formats

The journal encourages submissions that bridge fundamental discoveries with clinical or translational impact and contribute to evidence-based biomedical science. JBPT welcomes the following article formats:

• Original Research Articles
• Narrative / Systematic Reviews
• Meta-Analysis
• Scientific Communications
• Methodological Papers
• Technical Updates & Novelties
• Viewpoints & Commentaries
• Well-Documented Case Reports
• Editorials & Letters to the Editor

Scholarly Disciplines Covered

JBPT publishes scholarly work across a broad spectrum of biomedical and clinical disciplines, including but not limited to:

  • Biomolecular and cellular biology
  • Molecular mechanisms of disease and pathogenesis
  • Clinical diagnostics and laboratory medicine
  • Histopathology, molecular pathology, genomics, and immunopathology
  • Microbiology, virology, and infectious diseases
  • Hematology, oncology, clinical biochemistry, diagnostic biomarkers, and precision medicine
  • Broad spectrum in pharmacology, drug delivery, nanotherapeutics, therapeutic developments, vaccines, biologics, and precision medicine
  • Genetic techniques, gene expression, gene therapies, and gene regulation-based studies

Indexing Tracking & Digital Dissemination

JBPT is committed to enhancing the visibility, accessibility, and impact of published research. The journal follows international best practices in scholarly publishing to meet the technical and ethical requirements of reputable indexing and abstracting services.

Structured in Compliance with Reputable Indexing Targets

The digital framework is built to satisfy evaluation parameters for core academic repositories, registries, and discovery networks, including: Google Scholar, Crossref (for permanent DOI registration), Directory of Open Access Journals (DOAJ), and OAI-PMH compliant repositories. In coming years, JBPT intends to apply for further indexing such as EMBASE, Scopus, Web of Science and PubMed.

* Indexing timeline statement: Formal applications for evaluation and inclusion within these major databases will be progressively submitted as the journal fulfills required publication volumes, issue consistency, and qualitative benchmarks.